Eight new drugs added to P.E.I. formulary

Wayne Thibodeau wthibodeau@theguardian.pe.ca
Published on April 23, 2014
CETA drugs

Eight drugs have been added to the provincial formulary, making it easier for Islanders to access the medications they need, says Health Minister Doug Currie.

Since 2006-2007, spending on pharmacare programs in Prince Edward Island has increased by more than 40 per cent and government has added or expanded coverage of 203 medications to the list of drugs available through provincial drug programs.

“By reducing the price of generic drugs and introducing a Catastrophic Drug Program, Islanders now have better access to fair drug prices,” said Currie. “The department will also continue to review additional medications that can be added to the list of publicly-funded drugs based on the advice of expert reviews.”

    The most recent additions to the formulary include:

●    Entecavir (Baraclude) – for treatment of Hepatitis B

●    Adefovir Dipivoxil (Hepsera) – for treatment of Hepatitis B

●    Darunavir (Prezista) – for treatment of HIV/AIDS

●    Pazopanib (Votrient) – for treatment of metastatic clear cell

renal carcinoma

●    Ticagrelor (Brilinta) – for treatment of acute coronary


●    Epoprostenol Sodium (Caripul) – for treatment of Pulmonary

Arterial Hypertension

●    Boceprevir (Victrelis) – for the treatment of chronic

Hepatitis C infection (genotype 1)

●    Telaprevir (Incivek) – for the treatment of chronic Hepatitis

C infection (genotype 1)